Biomarkers for oxidative stress in patients with community-acquired pneumonia

Vilen Molotov-Luchanskiy (Karaganda, Kazakhstan), Vilen Molotov-Luchanskiy, Larissa Muravyova, Ryszhan Bakirova, Dmitriy Klyuyev, Lyudmila Demidchik, Yevgenia Kolesnikova

Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models
Session: Prognostic factors in pneumonia: from clinical observations to experimental models
Session type: Oral Presentation
Number: 3247
Disease area: Respiratory infections

Congress or journal article abstractE-posterSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Vilen Molotov-Luchanskiy (Karaganda, Kazakhstan), Vilen Molotov-Luchanskiy, Larissa Muravyova, Ryszhan Bakirova, Dmitriy Klyuyev, Lyudmila Demidchik, Yevgenia Kolesnikova. Biomarkers for oxidative stress in patients with community-acquired pneumonia. Eur Respir J 2015; 46: Suppl. 59, 3247

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Metabolic alteration in red blood cells from patients with community-acquired pneumonia
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015


Procalcitonin as etiological marker of severe community-acquired pneumonia
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013


Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015


Biomarkers and clinical stability in community-acquired pneumonia
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009


Biomarkers and community-adquired pneumonia (CAP) etiology
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012


Cardiac autonomic alterations impact early and late outcomes in patients with community-acquired pneumonia
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013


Biomarkers in community-acquired pneumonia: still searching for the one
Source: Eur Respir J, 53 (2) 1802469; 10.1183/13993003.02469-2018
Year: 2019



Cardiovascular autonomic alterations and severity of the disease in community-acquired pneumonia
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013


Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


Biomarkers and cardiovascular events in community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016



Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016


Modern etiology of severe community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016


Biomarkers and severity in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012


Biomarkers in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012

Late Breaking Abstract - Biomarkers for iron metabolism among patients hospitalized with community-acquired pneumonia caused by SARS-CoV-2, bacteria, and influenza
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021


Monitoring of pneumocystis jirovecii pneumonia by specialized pro-resolving mediators
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016

Various biomarkers of oxidative stress in patients with uncontrolled asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013


Relationship between etiologic diagnosis and prognosis in community-acquired pneumonia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015


The role of procalcitonin in predicting severity and clinical course of aspiration pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015


Biomarkers as complication predictors in community-acquired pneumonia
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011